Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03075540 · ClinicalTrials.gov registry record · NA
Enhancing At-risk Latina Women's Use of Genetic Counseling for Hereditary Breast and Ovarian Cancer
A NA study of Hereditary Breast and Ovarian Cancer, sponsored by Georgetown University.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
- 2
- Study locations
NCT03075540: Completed NA study of Hereditary Breast and Ovarian Cancer, sponsored by Georgetown University.
NCT03075540 is a NA study of Hereditary Breast and Ovarian Cancer that has completed, run by Georgetown University. The registered enrollment target is 88 participants, below the 589-participant average among 5 other Hereditary Breast and Ovarian Cancer trials with a reported enrollment target (85% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03075540, a NA study of Hereditary Breast and Ovarian Cancer, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
- 2
- Study locations
Study Summary
Compared to non-Latina Whites, Latinas have a higher prevalence of BRCA1/2 gene mutations but lower use of genetic cancer risk assessments services (GCRA). This study will develop and assess the impact of a novel culturally targeted media intervention to improve psychosocial outcomes and GCRA use in Latinas at-risk of hereditary breast and ovarian cancer. If the intervention is proven to be effective in a future randomized controlled trial, the intervention can be disseminated to clinics and adapted to other ethnic groups.
Primary Outcome
Participation in genetic counseling services
Conditions Studied
Interventions
- BEHAVIORAL Genetic Counseling and Testing YouTube Video
Study Locations (2)
District of Columbia
- Capital Breast Care Center - Washington D.C.
Virginia
- Nueva Vida - Alexandria
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2016-05-24 |
| Est. Completion | 2019-11-15 |
| Phase | NA |
What the finished NCT03075540 record still lists
NCT03075540 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 589-participant average among 5 other Hereditary Breast and Ovarian Cancer trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Hereditary Breast and Ovarian Cancer appearing as the primary indexed condition, and to 1 intervention - of which Genetic Counseling and Testing YouTube Video is the first listed.
NCT03075540 reports a single indexed study location in District of Columbia, Virginia.
Frequently Asked Questions
What is clinical trial NCT03075540 about?
NCT03075540 is a clinical study titled "Enhancing At-risk Latina Women's Use of Genetic Counseling for Hereditary Breast and Ovarian Cancer". Compared to non-Latina Whites, Latinas have a higher prevalence of BRCA1/2 gene mutations but lower use of genetic cancer risk assessments services (GCRA). This study will develop and assess the impact of a novel culturally targeted media intervention to improve psychosocial outcomes and GCRA use in...
What is the current status of trial NCT03075540?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2016-05-24. Estimated completion is 2019-11-15.
What conditions does trial NCT03075540 study?
This clinical trial studies the following conditions: Hereditary Breast and Ovarian Cancer.
What interventions are being tested in trial NCT03075540?
The interventions under investigation include: Genetic Counseling and Testing YouTube Video (BEHAVIORAL).
Who is sponsoring clinical trial NCT03075540?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03075540 being conducted?
This trial has 2 study locations across District of Columbia, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hereditary Breast and Ovarian Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
RECRUITING · NA
-
Scalable Communication Modalities for Returning Genetic Research Results
ACTIVE NOT RECRUITING · NA
-
Testing an Intelligent Tutoring System to Enhance Genetic Risk Assessment
COMPLETED · NA
-
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
RECRUITING
-
Genetic Risk: Whether, When, and How to Tell Adolescents
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI